| Mepha Pharma AG - Rivaroxaban-Amlodipin-Mepha 20 mg/5 mg, Tabletten | | 69789 | | 03 | | Rivaroxaban-Amlodipin-Mepha 20 mg/5 mg | | Tabletten | | B01AF | | Direct Factor Xa Inhibitors | | 26.09.2025 | | |
| | Composition | | rivaroxabanum 20 mg, amlodipinum 5 mg ut amlodipini besilas 6.93 mg, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum, natrii laurilsulfas, hypromellosum, calcii hydrogenophosphas, E 172 (rubrum), silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 1.48 mg. | | Packungsbestandteile | | Tablets | | | | Active Agent | Dose |
|---|
| Amlodipine | 5 mg | | Rivaroxabanum | 20 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Rubrum) | | | | Calcium Hydrogen Phosphate | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Hypromellosum | | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Laurilsulfas | | | | Pro Compresso | | | | Silica Colloidalis Anhydrica | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 30 | | | B | | Yes | | 006 | 90 | | | B | | Yes |
|
|
